SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLINIA, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.952
AS - Asia 12.525
EU - Europa 6.217
SA - Sud America 2.031
AF - Africa 288
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
Totale 48.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.459
SG - Singapore 4.680
CN - Cina 2.981
BR - Brasile 1.567
VN - Vietnam 1.480
UA - Ucraina 1.124
DE - Germania 1.099
IT - Italia 1.072
HK - Hong Kong 1.068
TR - Turchia 850
GB - Regno Unito 646
FI - Finlandia 450
BD - Bangladesh 382
PL - Polonia 356
FR - Francia 355
SE - Svezia 346
RU - Federazione Russa 341
IN - India 242
JP - Giappone 208
MX - Messico 207
CA - Canada 202
AR - Argentina 161
ID - Indonesia 157
ZA - Sudafrica 92
ES - Italia 82
NL - Olanda 81
IQ - Iraq 78
EC - Ecuador 67
CO - Colombia 66
AT - Austria 56
PK - Pakistan 52
BE - Belgio 48
UZ - Uzbekistan 46
VE - Venezuela 45
CL - Cile 40
SA - Arabia Saudita 40
MA - Marocco 39
LT - Lituania 35
TN - Tunisia 33
PY - Paraguay 31
KE - Kenya 27
PH - Filippine 27
IR - Iran 25
EG - Egitto 22
UY - Uruguay 22
CZ - Repubblica Ceca 20
MY - Malesia 20
JM - Giamaica 19
ET - Etiopia 18
JO - Giordania 18
AE - Emirati Arabi Uniti 16
PS - Palestinian Territory 16
AU - Australia 15
IL - Israele 15
PE - Perù 15
AZ - Azerbaigian 14
NP - Nepal 14
RO - Romania 14
DZ - Algeria 13
KR - Corea 12
AL - Albania 11
BO - Bolivia 10
CH - Svizzera 10
CR - Costa Rica 10
KZ - Kazakistan 10
TH - Thailandia 10
GR - Grecia 9
OM - Oman 9
NG - Nigeria 8
TW - Taiwan 8
HN - Honduras 7
HU - Ungheria 7
LB - Libano 7
NI - Nicaragua 7
SV - El Salvador 7
BG - Bulgaria 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
PA - Panama 6
RS - Serbia 6
DK - Danimarca 5
GA - Gabon 5
MD - Moldavia 5
PT - Portogallo 5
SN - Senegal 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CI - Costa d'Avorio 4
GE - Georgia 4
IE - Irlanda 4
KW - Kuwait 4
LV - Lettonia 4
LY - Libia 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GD - Grenada 3
GY - Guiana 3
Totale 47.971
Salva come PNG Salva come JPEG
Città #
Fairfield 3.010
Singapore 2.925
Woodbridge 2.710
Ashburn 2.701
Houston 1.612
San Jose 1.398
Seattle 1.259
Jacksonville 1.244
Ann Arbor 1.190
Chandler 1.097
Hong Kong 1.046
Wilmington 996
Cambridge 993
Santa Clara 871
Beijing 869
Ho Chi Minh City 463
Izmir 450
Dallas 446
Los Angeles 371
Nanjing 359
Warsaw 339
Hanoi 333
New York 309
Princeton 286
Addison 248
San Diego 248
Lauterbourg 239
Ferrara 235
Council Bluffs 212
Munich 202
Boardman 199
Tokyo 196
Milan 175
São Paulo 151
Helsinki 140
Shanghai 126
Nanchang 119
Buffalo 117
Mexico City 112
Orem 107
Jakarta 102
London 95
Shenyang 93
Dearborn 91
Hebei 84
Tianjin 84
The Dalles 83
Hefei 80
Bremen 71
Turku 70
Atlanta 69
Denver 68
Da Nang 67
Toronto 67
Chicago 65
Falls Church 65
Brooklyn 61
Haiphong 61
Mountain View 59
Jiaxing 57
San Mateo 57
Frankfurt am Main 56
Johannesburg 56
Stockholm 55
Jinan 52
Changsha 50
Rio de Janeiro 50
Montreal 49
Redwood City 47
Rome 47
Falkenstein 45
Brussels 44
Chennai 43
Boston 42
Columbus 42
Amsterdam 41
Moscow 41
Nuremberg 40
Guangzhou 39
Kunming 39
Tashkent 39
Mumbai 38
Belo Horizonte 37
San Francisco 36
Bologna 35
Manchester 35
Phoenix 34
Baghdad 33
Poplar 33
Norwalk 31
Dong Ket 30
Ankara 29
Ningbo 29
Brasília 28
Des Moines 27
Hangzhou 27
Orange 27
Philadelphia 27
Porto Alegre 27
Vienna 27
Totale 33.159
Salva come PNG Salva come JPEG
Nome #
Loss of miR-204 expression is a key event in melanoma 285
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 275
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 272
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 256
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 255
Correlation of expression between different IMAGE clones from the same UniGene cluster 255
MicroRNA expression profiling in human Barrett's carcinogenesis. 255
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 255
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 253
MicroRNA Expression Signatures in Solid Malignancies 251
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 249
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 240
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 240
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples 239
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 237
Identification of microRNA activity by Targets' Reverse EXpression. 236
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 229
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 228
Reprogramming of miRNA networks in cancer and leukemia 225
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 225
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 223
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 223
Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray 221
Microevolution in Ferrara: Isonymy 1890–1990 221
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 220
GAMES identifies and annotates mutations in next-generation sequencing projects 220
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 219
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 216
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 216
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 216
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia 215
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 215
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 214
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 213
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 212
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 211
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 210
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 209
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 208
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 208
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 207
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 206
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 202
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 202
Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer 202
Espressione dei MicroRNA nei carcinomi mammari 201
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 199
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 199
TOM: Transcriptomics of OMIM. 198
Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations 197
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 195
CG Dinucleotides of class II MHC genes are mutation hot-spots 195
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 195
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 195
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 194
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 193
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 193
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia 192
Partial gene deletion in a family with factor X deficiency 191
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 191
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 191
SNPs and somatic mutation on long non-coding RNA: New frontier in the cancer studies? 191
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 189
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. 189
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 189
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 188
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. 187
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome 187
Expression profiles of craniosynostosis-derived fibroblasts 185
The role of microRNA genes in papillary thyroid carcinoma 184
The miR-1792 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes 183
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 183
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 182
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 180
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 180
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 179
GOAL: automated gene ontology analisys of expression profiles. 175
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 175
The network of non-coding RNAs in cancer drug resistance 175
Modulation of mismatch repair and genomic stability by miR-155 175
MicroRNA profiles discriminate among colon cancer metastasis 174
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 173
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 173
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 172
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 172
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 172
A microRNA expression signature of human solid tumors defines cancer gene targets 171
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 171
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 170
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 170
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 167
The network of non-coding RNAs and their molecular targets in breast cancer 166
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression 165
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials 164
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 164
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 164
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 164
Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways 163
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality 163
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8 163
Totale 20.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 202.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.371
Totale 204.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.197 174 363 351 56 137 117 155 116 93 243 293 1.099
2022/20232.647 275 114 90 300 443 409 115 247 367 26 166 95
2023/20241.240 155 203 61 38 74 177 63 61 31 25 51 301
2024/20255.665 155 154 476 211 697 441 186 393 931 626 768 627
2025/202616.943 1.506 749 1.585 2.156 2.337 990 1.991 990 1.669 1.740 825 405
2026/2027418 418 0 0 0 0 0 0 0 0 0 0 0
Totale 48.448